Treatment of cerebral aspergillosis after liver transplantation

Neurology. 1992 Sep;42(9):1817-9. doi: 10.1212/wnl.42.9.1817.

Abstract

We report the treatment of cerebral aspergillosis with amphotericin B, flucytosine, surgery, and liposomal amphotericin B (L-AmB) after a liver transplant. The patient died 2 months after cessation of antifungal therapy, as a consequence of multiple-system organ failure. The only relevant postmortem finding in the brain was a small, encapsulated abscess containing hyphae. This case indicates that L-AmB is an effective alternative drug for cerebral aspergillosis.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Aspergillosis / etiology
  • Aspergillosis / therapy*
  • Aspergillus fumigatus* / isolation & purification
  • Brain Diseases / microbiology
  • Brain Diseases / therapy*
  • Combined Modality Therapy
  • Flucytosine / therapeutic use
  • Humans
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Opportunistic Infections / therapy*

Substances

  • Amphotericin B
  • Flucytosine